Company: PTHS
Filing Date: 2025-04-17
Form Type: 8-K
Source: 0001753926-25-000652
Chunk: 10

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-04-17
Form: 8-K
Item: Item 1.01
Chunk 10
---
 the SEC, pursuant to Item 304(a)(3) of Regulation S-K, stating whether it agrees with the above statements and, if it does not
agree, the respects in which it does not agree. A copy of the letter, dated April 17, 2025, is filed as Exhibit 16.1 (which is
incorporated by reference herein) to this Current Report on Form 8-K.

Item 5.07. Submission of Matters to
a Vote of Security Holders

The disclosure set forth above in the paragraph
titled, “ Stockholder Approval of Transaction” in Item 1.01 of this Current Report on Form 8-K is incorporated
by reference into this Item 5.07. Channel intends to file with the SEC, and mail to its stockholders, an information statement
on Schedule 14C describing the Merger Agreement and the transactions contemplated thereby.

Item 7.01. Regulation FD Disclosure